Previous studies have shown that E2F2 is an oncogene in many tumor types, for instance, it has been discovered that E2F2 is prominently up-regulated in NSCLC, and can be serve as a therapeutic target to prevent the proliferation and invasion of NSCLC [4]. Here, E2F2 is linked to neoplasm.